Palatin completes study enrolment of bremelanotide plus tirzepatide to treat obesity
Palatin Technologies has completed enrolment in the study entitled "BMT-801, A Phase II, Randomized, Double-Blind, Placebo-Controlled,...
top of page
Browse by category
Search
TENN-LABS: Ten-year outcomes show long-term benefits of surgery in young people
Ten years after undergoing bariatric surgery as adolescents, over half of participants in the Teen-Longitudinal Assessment of Bariatric...
GT Metabolic's MagDI System for side-to-side DI anastomosis to "revolutionise industry" after FDA approval
GT Metabolic Solutions has received FDA clearance of its MagDI System for side-to-side duodeno-ileal (DI) anastomosis. The MagDI System...
One in five BMS patients benefit from preoperative ultrasound
Almost one in five patients benefitted from a preoperative ultrasound before undergoing bariatric metabolic surgery (BMS) with 15.9% of...
Journal Watch 30/10/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Multisociety clinical practice guidance says most patients can continue GLP-1 anti-obesity drugs before surgery
Most patients may continue to safely take glucagon-like peptide-1 (GLP-1) receptor agonists as prescribed before undergoing elective...
Oxford Medical Products’ Sirona inert dual-polymer hydrogel pill can result in 10% TBWL
Oxford Medical Products has announced positive topline results from the first randomised controlled trial (RCT) of Sirona, its...
Bariatric patients see post-surgical increase in earnings out to five years
Patients who received bariatric surgery saw a sustained average increase in earnings from six months to five years after surgery among...
FDA grants De Novo approval for Distalmotion’s Dexter Surgical Robot for adult inguinal hernia repair
Distalmotion has been granted De Novo approval by the FDA to market the Dexter Surgical Robot for adult inguinal hernia repair. This...
Semaglutide has positive effect in chronic kidney disease
Semaglutide has a positive effect on patients with chronic kidney disease and obesity. By decreasing the amount of protein in urine, the...
Browse by tag
bottom of page